home / stock / ttoo / ttoo news


TTOO News and Press, T2 Biosystems Inc.

Stock Information

Company Name: T2 Biosystems Inc.
Stock Symbol: TTOO
Market: NASDAQ
Website: t2biosystems.com

Menu

TTOO TTOO Quote TTOO Short TTOO News TTOO Articles TTOO Message Board
Get TTOO Alerts

News, Short Squeeze, Breakout and More Instantly...

TTOO - T2 Biosystems extends contract with Vizient

2024-03-28 09:36:30 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems receives extension to comply with Nasdaq listing requirement T2 Biosystems says it achieved full year 2023 total revenue of $7.2M Seeking Al...

TTOO - T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driv...

TTOO - T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates

LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans for the T2Lyme Panel commercial launch and provided recent busin...

TTOO - T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates

LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that Company management will host a conference call to discuss the T2L...

TTOO - T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel

LEXINGTON, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the publication of a new study highlighting the clinical benefits...

TTOO - T2 Biosystems receives extension to comply with Nasdaq listing requirement

2024-03-12 10:03:27 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems says it achieved full year 2023 total revenue of $7.2M T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha ...

TTOO - T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement

LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listin...

TTOO - T2 Biosystems, AMN Healthcare Services among healthcare movers

2024-02-16 10:00:07 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...

TTOO - T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript

2024-02-15 19:37:10 ET T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Conference Call February 15, 2024, 04:30 PM ET Company Participants Trip Taylor - IR John Sperzel - Chairman & CEO John Sprague - John Sprague Conference Call Participants Ben Hayn...

TTOO - T2 Biosystems says it achieved full year 2023 total revenue of $7.2M

2024-02-15 16:12:27 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...

Next 10